Follow
MD SHAMSUZZAMAN
MD SHAMSUZZAMAN
Food and Drug Administration; University of Maryland Baltimore County; Philips Research North
Verified email at fda.hhs.gov
Title
Cited by
Cited by
Year
The small and large ribosomal subunits depend on each other for stability and accumulation
B Gregory, N Rahman, A Bommakanti, M Shamsuzzaman, M Thapa, ...
Life science alliance 2 (2), 2019
502019
Repressed synthesis of ribosomal proteins generates protein-specific cell cycle and morphological phenotypes
M Thapa, A Bommakanti, M Shamsuzzaman, B Gregory, L Samsel, ...
Molecular biology of the cell 24 (23), 3620-3633, 2013
402013
The extended loops of ribosomal proteins uL4 and uL22 of Escherichia coli contribute to ribosome assembly and protein translation
MG Lawrence, M Shamsuzzaman, M Kondopaka, C Pascual, JM Zengel, ...
Nucleic acids research 44 (12), 5798-5810, 2016
332016
Identifying simple sequence repeat (SSR) marker linked to mite tolerance in jute species
SI Keka, M Shamsuzzaman, MU Pahloan, S Pervin, MM Rahman, H Khan
Bangladesh Journal of Botany 37 (2), 161-171, 2008
202008
Analysis of cell cycle parameters during the transition from unhindered growth to ribosomal and translational stress conditions
M Shamsuzzaman, A Bommakanti, A Zapinsky, N Rahman, C Pascual, ...
PLoS One 12 (10), e0186494, 2017
92017
Identifying Predictors for All-Cause Mortality in Diabetic Patients in the ACCORD Trial Using Random Survival Forests
AH Md Shamsuzzaman, Tejas Patel, Eileen Navarro, Colin O. Wu, Bereket ...
Circulation 136 (Suppl 1), 18043, 2017
82017
Interaction between the assembly of the ribosomal subunits: disruption of 40S ribosomal assembly causes accumulation of extra-ribosomal 60S ribosomal protein uL18/L5
N Rahman, M Shamsuzzaman, L Lindahl
PLoS One 15 (1), e0222479, 2020
52020
Exploring the role of astrocytic dysfunction and AQP4 in depression
T Rana, T Behl, M Shamsuzzaman, S Singh, N Sharma, A Sehgal, ...
Cellular Signalling 96, 110359, 2022
42022
Improving disease named entity recognition for clinical trial matching
MAAH Khan, M Shamsuzzaman, SA Hasan, MS Sorower, J Liu, V Datla, ...
2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2019
42019
Inhibition of Ribosome Assembly and Ribosome Translation Has Distinctly Different Effects on Abundance and Paralogue Composition of Ribosomal Protein mRNAs in Saccharomyces …
M Shamsuzzaman, N Rahman, B Gregory, A Bommakanti, JM Zengel, ...
Msystems 8 (1), e01098-22, 2023
22023
Correction: The small and large ribosomal subunits depend on each other for stability and accumulation
B Gregory, N Rahman, A Bommakanti, M Shamsuzzaman, M Thapa, ...
Life Sci Alliance 2 (4), 2019
22019
Variability in Baseline Liver Test Values in Clinical Trials: Challenges in Enhancing Drug-Induced Liver Injury Assessment in Subjects with Liver Disease
B Tesfaldet, G Csako, T Patel, M Shamsuzzaman, EN Almario
Drug-Induced Liver Toxicity, 431-457, 2018
12018
Predictors of Hospitalization or Death Due to Heart Failure in Diabetic Patients by Gender in the ACCORD Trial Using Random Survival Forests
AH Tejas Patel, Md Shamsuzzaman, Eileen Navarro, Colin O. Wu, Bereket ...
Circulation 136 (Supplement 1), 18061, 2017
12017
P809: BASELINE CHARACTERISTICS IDENTIFYING PATIENTS WITH MULTIPLE MYELOMA TREATED WITH IDECABTAGENE VICELEUCEL (IDE-CEL; BB2121) WHO ARE AT RISK FOR SEVERE/REFRACTORY …
A Mashadi-Hossein, J Rytlewski, MD Shamsuzzaman, D Basudhar, ...
HemaSphere 7 (S3), e1004207, 2023
2023
Baseline characteristics identifying patients (pts) with multiple myeloma (MM) treated with idecabtagene vicleucel (ide-cel; bb2121) who are at risk for severe/refractory …
A Mashadi-Hossein, J Rytlewski, M Shamsuzzaman, D Basudhar, ...
Journal of Clinical Oncology 41 (16_suppl), e20005-e20005, 2023
2023
Polyphenols inhibiting MAPK signaling pathway mediated oxidative stress and inflammation in depression
M Shamsuzzaman, M Shamsuzzaman, T Behl
Biomedicine and Pharmacotherapy, 2021
2021
Mosaic changes to the global transcriptome in response to inhibiting ribosome formation versus inhibition of ribosome function
M Shamsuzzaman, N Rahman, B Gregory, VM Bruno, L Lindahl
bioRxiv, 2020.10. 15.341230, 2020
2020
BoostER: A Performance Boosting Module for Biomedical Entity Recognition
R Pandey, M Shamsuzzaman, SA Hasan, MS Sorower, MAAH Khan, J Liu, ...
2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2019
2019
Re-Use of Clinical Trial Data From the NHLBI Data Repository (BioLINCC) for Patient-Level Meta-Analyses of Cardiovascular Outcomes: Challenges and Opportunities
H Sviglin, G Dandi, E Navarro Almario, T Patel, CO Wu, X Tian, G Csako, ...
Circulation 138 (Suppl_1), A17059-A17059, 2018
2018
Predictors of Death and Major Adverse Cardiovascular Events in the ACCORD Trial Identified by Random Survival Forest Based Machine-Learning
M Shamsuzzaman, E Navarro Almario, T Patel, G Csako, CO Wu, X Tian, ...
Circulation 138 (Suppl_1), A17121-A17121, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20